Built To Fail: How Today's Manufacturing Options Leave Pharma At Risk

By Joe Principe, Vice President, Strategic Partnerships, Thermo Fisher Scientific

By Joe Principe, Vice President, Strategic Partnerships, Patheon

When planning for the development of a new product, a pharmaceutical manufacturer must determine very early in the process what a product’s anticipated demand will be at the time of launch. Not only is this very difficult to do, but also the consequences of incorrect forecasts can be very costly in a number of ways. Without the ability to predict capacity needs with 100% accuracy, pharma must come up with an effective way to eliminate demand risks.